Sort by
Refine Your Search
-
Listed
-
Employer
- ICN2
- Institut de Recerca Biomèdica de Lleida, Fundació Dr. Pifarré (IRBLleida)
- Institute for bioengineering of Catalonia, IBEC
- Institute of Chemical Research of Catalonia ICIQ
- UNIVERSIDAD POLITECNICA DE MADRID
- Autonomous University of Madrid (Universidad Autónoma de Madrid)
- BIOGIPUZKOA HEALTH RESEARCH INSTITUTE
- Universitat Rovira i Virgili
- Basque Center for Macromolecular Design and Engineering, POLYMAT Fundazioa
- CIC bioGUNE
- Centre for Genomic Regulation
- Computer Vision Center
- FUNDACIÓ ESADE - UNIVERSITAT RAMON LLULL
- Forest Science and Technology Centre of Catalonia
- Fundacion IMDEA Energia
- Fundació Centre de Recerca en Agrotecnologia-AGROTECNIO
- Fundación IIS Aragón
- Fundación IMDEA Materiales
- ICMAB
- ISGLOBAL
- Institut Barcelona d'Estudis Internacionals
- Institut Català de Nanociència i Nanotecnologia
- Institut d'Investigació Biomèdica Sant Pau
- Institut de Físiques d'Altes Energies (IFAE)
- Institute of Photonic Sciences
- Instituto de Neurociencia Avanzada de Barcelona
- Josep Carreras Leukaemia Research Institute (IJC)
- Maimonides Biomedical Research Institute of Cordoba - IMIBIC
- State Key Laboratory of Ultrasound in Medicine and Engineering, Chongqing Medical University.
- The Chinese Institutes for Medical Research (CIMR), Beijing
- UNIOVI
- Universidad de Sevilla
- Universitat Politècnica de Catalunya
- Universitat Politècnica de València
- Universitat Pompeu Fabra
- Universitat de Barcelona
- University of Deusto
- 27 more »
- « less
-
Field
-
to join the research team led by Ana Martínez Riaño. The project is focused on understanding how anti-tumoral immune responses are developed and organized within tumors, with specific emphasis on the role
-
for three consecutive periods (2014-2018 and 2018-2022 and 2023-2026). ICN2 comprises 20 Research Groups, 7 Technical Development and Support Units and Facilities, and 2 Research Platforms, covering different
-
function of these cells, we combine directed differentiation of human pluripotent stem cells, in vitro and in vivo models of human normal and leukemic development, and state-of-the-art epigenomic and
-
for three consecutive periods (2014-2018 and 2018-2022 and 2023-2026). ICN2 comprises 20 Research Groups, 7 Technical Development and Support Units and Facilities, and 2 Research Platforms, covering different
-
resistance. We developed synthetic cells that fight bacteria using a biomimetic form of artificial phagocytosis, a process to date only observed in living organisms. These phagocytic synthetic cells (PSCs
-
detector Characterization Group. IFAE is a worldwide-recognized center for fundamental research in Particle Physics, Astro particle Physics and Cosmology, as well as for developing state-of-the-art
-
movilidad regional/ Development of Regional Mobility Surveys Explotación de resultados de cuestionarios (comercio y movilidad)/ Analysing the results of different surveys (related to commerce and mobility
-
(2014-2018 and 2018-2022 and 2023-2026). ICN2 comprises 20 Research Groups, 7 Technical Development and Support Units and Facilities, and 2 Research Platforms, covering different areas of nanoscience and
-
, reports and proposals, and establish interdisciplinary collaborations. The position will also involve supervision of undergraduate students and the development of research projects with strong translational
-
the context of inflammatory diseases. The postdoctoral researcher will be expected to independently design, execute, evaluate, and interpret experimental assays, as well as to contribute to the development